Gene array analysis comparison between rat collagen-induced arthritis and human rheumatoid arthritis

Scandinavian Journal of Immunology

Volumn 68, Issue 1, 2008, Pages 43-57

  Soto, H ^a   Hevezi, P ^a   Roth, R B ^a   Pahuja, A ^a   Alleva, D ^a   Acosta, H M ^b   Martinez, C ^b   Ortega, A ^b   Lopez, A ^b   Araiza Casillas, R ^b,c   Zlotnik, A ^a,d  

^a NEUROCRINE BIOSCIENCES INC   (United States)

^b UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

^c Department of Internal Medicine Rheumatology   (Mexico)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; CD20 ANTIBODY; CHEMOKINE; CXCL13 CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTHRITIS; ARTICLE; DENDRITIC CELL; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS;

EID: 44849125082     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02117.x     Document Type: Article

References (44)

1. Feldmann M, Brennan FM, Paleolog E et al. Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease? Novartis Found Symp 2004 256 : 53.
2. Feldmann M, Brennan FM, Foxwell BM, Taylor PC, Williams RO, Maini RN. Anti-TNF therapy: where have we got to in 2005? J Autoimmun 2005 25 (Suppl. 26.
3. Klareskog L, van der Heijde D, de Jager JP et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004 363 : 675.
4. Kannan K, Ortmann RA, Kimpel D. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology 2005 12 : 167.
5. Ibrahim SM, Koczan D, Thiesen HJ. Gene-expression profile of collagen-induced arthritis. J Autoimmun 2002 18 : 159.
6. Thornton S, Sowders D, Aronow B et al. DNA microarray analysis reveals novel gene expression profiles in collagen-induced arthritis. Clin Immunol 2002 105 : 155.
7. Gierer P, Ibrahim S, Mittlmeier T et al. Gene expression profile and synovial microcirculation at early stages of collagen-induced arthritis. Arthritis Res Ther 2005 7 : R868.
8. van der Pouw Kraan TC, van Gaalen FA, Huizinga TW, Pieterman E, Breedveld FC, Verweij CL. Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair. Genes Immun 2003 4 : 187.
9. Jarvis JN, Dozmorov I, Jiang K et al. Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis. Arthritis Res Ther 2004 6 : R15.
10. Devauchelle V, Marion S, Cagnard N et al. DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets. Genes Immun 2004 5 : 597.
11. Tsubaki AN, Kawakami T, Shiratsuchi TTN et al. Characterization of histopathology and gene-expression profiles of synovitis in early rheumatoid arthritis using targeted biopsy specimens. Arthritis Res Ther. 2005 7 : R825.
12. Burmester GR, Haupl T. Strategies using functional genomics in rheumatic diseases. Autoimmun Rev 2004 3 : 541.
13. Haupl T, Krenn V, Stuhlmuller B, Radbruch A, Burmester GR. Perspectives and limitations of gene expression profiling in rheumatology: new molecular strategies. Arthritis Res Ther 2004 6 : 140.
14. Oertelt S, Selmi C, Invernizzi P, Podda M, Gershwin ME. Genes and goals: an approach to microarray analysis in autoimmunity. Autoimmun Rev 2005 4 : 414.
15. Seidel MF, Keck R, Vetter H. ICAM-1/LFA-1 expression in acute osteodestructive joint lesions in collagen-induced arthritis in rats. J Histochem Cytochem 1997 45 : 1247.
16. Arnett FC. Revised criteria for the classification of rheumatoid arthritis. Bull Rheum Dis 1989 38 : 1.
17. Adarichev VA, Vermes C, Hanyecz A, Mikecz K, Bremer EG, Glant TT. Gene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation. Arthritis Res Ther 2005 7 : R196.
18. Wang D, Bromme D. Drug delivery strategies for cathepsin inhibitors in joint diseases. Expert Opin Drug Deliv 2005 2 : 1015.
19. Berahovich RD, Miao Z, Wang Y, Premack B, Howard MC, Schall TJ. Proteolytic activation of alternative CCR1 ligands in inflammation. J Immunol 2005 174 : 7341.
20. Menten P, Proost P, Struyf S et al. Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-alpha/beta and interferon-gamma reveals MCP-3 heterogeneity. Eur J Immunol 1999 29 : 678.
21. Page G, Lebecque S, Miossec P. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. J Immunol 2002 168 : 5333.
22. Mahmoud RK, El-Ansary AK, El-Eishi HH, Kamal HM, El-Saeed NH. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis. Ital J Biochem 2005 54 : 248.
23. Rannou F, Francois M, Corvol MT, Berenbaum F. Cartilage breakdown in rheumatoid arthritis. Joint Bone Spine 2006 73 : 29.
24. Prod'homme T, Weber MS, Steinman L, Zamvil SS. A neuropeptide in immune-mediated inflammation, Y? Trends Immunol 2006 27 : 164.
25. Calvano SE, Xiao W, Richards DR et al. A network-based analysis of systemic inflammation in humans. Nature 2005 437 : 1032.
26. Holmdahl R. Dissection of the genetic complexity of arthritis using animal models. Immunol Lett 2006 103 : 86.
27. Shou J, Bull CM, Li L et al. Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model. Arthritis Res Ther 2006 8 : R28.
28. van't Veer LJ, Dai H, van de Vijver MJ et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002 415 : 530.
29. Selman M, Pardo A, Barrera L et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 2006 173 : 188.
30. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000 18 : 217.
31. Tamamura H, Fujisawa M, Hiramatsu K et al. Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent. FEBS Lett 2004 569 : 99.
32. Seyler TM, Park YW, Takemura S et al. BLyS and APRIL in rheumatoid arthritis. J Clin Invest 2005 115 : 3083.
33. Ng LG, Mackay CR, Mackay F. The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol 2005 42 : 763.
34. Rahman ZS, Rao SP, Kalled SL, Manser T. Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice. J Exp Med 2003 198 : 1157.
35. Starnes T, Broxmeyer HE, Robertson MJ, Hromas R. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol 2002 169 : 642.
36. Hwang SY, Kim HY. Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Mol Cells 2005 19 : 180.
37. Patino-Lopez G, Hevezi P, Lee J et al. Human class-I restricted T cell associated molecule is highly expressed in the cerebellum and is a marker for activated NKT and CD8 + T lymphocytes. J Neuroimmunol 2006 171 : 145.
38. Rutkauskaite E, Volkmer D, Shigeyama Y et al. Retroviral gene transfer of an antisense construct against membrane type 1 matrix metalloproteinase reduces the invasiveness of rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2005 52 : 2010.
39. Baramova EN, Bajou K, Remacle A et al. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation. FEBS Lett 1997 405 : 157.
40. Ishikawa T, Nishigaki F, Miyata S et al. Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031. Br J Pharmacol 2005 144 : 133.
41. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci 2006 11 : 529.
42. Fiedorczyk M, Klimiuk PA, Sierakowski S, Domyslawska I, Chwiecko J. Correlations between serum matrix metalloproteinase (MMP-1, MMP-3, MMP-9, MMP-13) concentrations and markers of disease activity in early rheumatoid arthritis. Przegl Lek 2005 62 : 1321.
43. Malemud CJ. Matrix metalloproteinases(MMPs) in health and disease: an overview. Front Biosci 2006 11 : 1696.
44. Hasler P. Biological therapies directed against cells in autoimmune disease. Springer Semin Immunopathol 2006 27 : 443.